13G Filing: JPMorgan Chase & Co and Kite Pharma Inc. (KITE)

Page 3 of 3

Page 3 of 3 – SEC Filing

SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and correct.
  JPMorgan Chase & Co
 
       

Date:
October 05, 2017
By:
/s/
Michael T. Lees
 
   
Name: Michael T. Lees
 
   
Title:
Executive Director
 
       
Footnotes:
Attention:
Intentional
misstatements or omissions of fact constitute Federal criminal violations (See
18 U.S.C. 1001)
 

Follow Kite Pharma Inc. (NASDAQ:KITE)

Page 3 of 3